Pfizer Inc. (BMV: PFE)

Market Cap	3.11T
Revenue (ttm)	1.16T
Net Income (ttm)	83.34B
Shares Out	n/a
EPS (ttm)	14.59
PE Ratio	37.35
Forward PE	n/a
Dividend	31.96 (5.84%)
Ex-Dividend Date	Jan 24, 2025

Volume	n/a
Average Volume	3,532
Open	550.00
Previous Close	550.00
Day's Range	547.00 - 555.71
52-Week Range	429.00 - 597.50
Beta	0.62
RSI	53.91
Earnings Date	Feb 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and po...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 88,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2023, Pfizer's revenue was $58.50 billion, a decrease of -41.70% compared to the previous year's $100.33 billion. Earnings were $2.12 billion, a decrease of -93.25%.

Financial numbers in USD